Kane BiotechKNBIF +5.19% 5-Day RSI is 29.42 as of Jun. 25, 2026. The stock has 6 warning signs investors should review. Among 1,424 Biotechnology companies, Kane Biotech ranks better than 80.27% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-25), Kane Biotech's 5-Day RSI is 29.42.
The industry rank for Kane Biotech's 5-Day RSI or its related term are showing as below:
KNBIF's 5-Day RSI is ranked better than 80.27% of 1424
companies
in the Biotechnology industry
Industry Median: 48.55
vs KNBIF: 29.42
Kane Biotech (OTCPK:KNBIF) 5-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Kane Biotech 5-Day RSI Related Terms
KNBIF vs VRTX, REGN, ALNY: 5-Day RSI Comparison
For the Biotechnology subindustry, Kane Biotech's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kane Biotech 5-Day RSI vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kane Biotech's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Kane Biotech's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kane Biotech (KNBIF) has a 5-Day RSI of 29.42 as of Jun. 25, 2026. According to the industry distribution chart, Kane Biotech ranks #281 out of 1424 companies in the Biotechnology industry, placing it in the top 19.7%.
Is Kane Biotech's 5-Day RSI too high?
Kane Biotech's current 5-Day RSI is 29.42. The Biotechnology industry median 5-Day RSI is 48.55. Kane Biotech's value of 29.42 is 39.4% below this industry median. Based on the distribution chart, Kane Biotech ranks #281 out of 1424 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Kane Biotech's 5-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #281 out of 1424 companies for 5-Day RSI. This places Kane Biotech in the top 20% of its industry — outperforming the majority of peers. The industry median 5-Day RSI is 48.55. Kane Biotech's value of 29.42 is 39.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Biotechnology company?
The median 5-Day RSI among Biotechnology companies is 48.55, based on 1,424 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kane Biotech's current 5-Day RSI of 29.42 is 39.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median 5-Day RSI is 48.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kane Biotech's current 5-Day RSI is 29.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current 5-Day RSI of 29.42. The current 5-Day RSI is 29.42 and 39.4% below the Biotechnology industry median of 48.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current 5-Day RSI is 29.42 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNBIF has been successfully added to your